ABMD Technical Analysis
As of date:9/25/2020
ABMD stock price:266.44
ABMD 50 DMA:293.81
ABMD 200 DMA:214.91
ABMD MACD (200-50):-78.90
ABMD RSI:43.41
Extremely
Overbought
Overbought/Oversold RSI Range
RSI Indicator (Relative Strength Index)43.41
Extremely
Oversold

Also see:
ABMD Market Cap History
ABMD Shares Outstanding History
ABMD YTD Return

Quotes delayed 20 minutes
Get Free SEC filing alerts for ABMD:
ABMD SEC Filing Email Alerts ServiceExternal link

So-Young International Breaks Above 200-Day Moving Average - Bullish for SY
19 minutes ago


Red Violet Breaks Above 200-Day Moving Average - Bullish for RDVT
19 minutes ago


Impinj Breaks Above 200-Day Moving Average - Bullish for PI
20 minutes ago


LATN Makes Notable Cross Below Critical Moving Average
20 minutes ago


FREQ Makes Notable Cross Below Critical Moving Average
20 minutes ago


Ultra Clean Holdings Breaks Above 200-Day Moving Average - Bullish for UCTT
1 hour, 20 minutes ago


Bullish Two Hundred Day Moving Average Cross - STOR
1 hour, 20 minutes ago


Virgin Galactic Holdings Shares Cross Above 200 DMA
1 hour, 20 minutes ago


SeaWorld Entertainment Shares Cross Above 200 DMA
1 hour, 20 minutes ago


RP Makes Bullish Cross Above Critical Moving Average
1 hour, 21 minutes ago


PTY Crosses Above Key Moving Average Level
1 hour, 21 minutes ago


Preformed Line Products Shares Cross Above 200 DMA
1 hour, 21 minutes ago


PARR Stock Crowded With Sellers
1 hour, 22 minutes ago


OMF Crosses Above Key Moving Average Level
1 hour, 22 minutes ago


OEC Makes Bullish Cross Above Critical Moving Average
1 hour, 22 minutes ago


More Technical Analysis News

ABMD Technical AnalysisABMD RSI
ABIOMED develops, manufactures and markets products that are designed to enable the heart to rest, heal and recover by improving blood flow to the coronary arteries and end-organs and/or temporarily assisting the pumping function of the heart. Co.'s products include: Impella 2.5®, which is a percutaneous micro heart pump with an integrated motor and sensors; Impella CP®, which provides more blood flow than the Impella 2.5; Impella RP®, which is a percutaneous catheter-based axial flow pump; and Impella Connect®, which is a cloud-based technology that enables remote viewing of the Automated Impella Controller for physicians and hospital staff from anywhere with internet connectivity.

When researching a stock like ABIOMED, many investors are the most familiar with Fundamental Analysis — looking at a company's balance sheet, earnings, revenues, and what's happening in that company's underlying business. Investors who use Fundamental Analysis to identify good stocks to buy or sell can also benefit from ABMD Technical Analysis to help find a good entry or exit point. Technical Analysis is blind to the fundamentals and looks only at the trading data for ABMD stock — the real life supply and demand for the stock over time — and examines that data in different ways.
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks

10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
ABMD DMAABMD MACD
Video: Technical Analysis


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
ABIOMED (ABMD) is categorized under the Healthcare sector; to help you further research Technical Analysis, below are some other companies in the same sector:

ABT Technical Analysis
AGN Technical Analysis
ALGN Technical Analysis
ALXN Technical Analysis
AMGN Technical Analysis
BAX Technical Analysis
BDX Technical Analysis
BIIB Technical Analysis
BMY Technical Analysis
BSX Technical Analysis
More Healthcare companies »

 

ABMD Technical Analysis | www.TechnicalAnalysisChannel.com | Copyright © 2019 - 2020, All Rights Reserved

Nothing in TechnicalAnalysisChannel.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.